FAKTOR-OPTIONSSCHEIN - TANDEM DIABETES CARE Stock

Certificat

DE000ME42C24

Delayed Börse Stuttgart 15:37:41 2024-06-26 EDT
16.25 EUR +2.20% Intraday chart for FAKTOR-OPTIONSSCHEIN - TANDEM DIABETES CARE
Current month-85.79%
1 month-81.88%
Date Price Change
24-06-26 16.25 +2.20%
24-06-25 15.9 -37.00%
24-06-24 25.24 +4.30%
24-06-21 24.2 -11.19%
24-06-20 27.25 +3.10%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 03:37 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer Morgan Stanley
WKN ME42C2
ISINDE000ME42C24
Date issued 2023-11-22
Strike 33.87 $
Maturity Unlimited
Parity 0.37 : 1
Emission price 10
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 114.3
Lowest since issue 8.82
Spread 1.06
Spread %6.03%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
40.64 USD
Average target price
49.93 USD
Spread / Average Target
+22.87%
Consensus